Radiopharm Theranostics Ltd (RADX) Minority Interest (2024 - 2025)
Radiopharm Theranostics (RADX) posted quarterly Minority Interest of -$12297.0 for Q2 2025, down 142.56% year-over-year from $28895.2 in Q2 2024, and down 142.56% quarter-over-quarter from -$5069.7 in Q2 2024.
Radiopharm Theranostics Ltd (RADX) Minority Interest (2024 - 2025) Analysis & Trends
Radiopharm Theranostics (RADX) has reported Minority Interest for 2 consecutive years, with -$12297.0 the latest figure, recorded in Q2 2025.
- In Q2 2025, Minority Interest fell 142.56% year-over-year to -$12297.0; the TTM figure through Jun 2025 stood at -$12297.0 (down 142.56% YoY), while the FY2025 annual figure was -$12297.0, down 142.56% from the prior year.
- Minority Interest slipped to -$12297.0 in Q2 2025 per RADX's latest filing, from -$5069.7 in the prior quarter.
- Across five years, Minority Interest topped out at -$5069.7 in Q2 2024 and bottomed at -$12297.0 in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -12,296.96 |
| Jun 30, 2024 | -5,069.72 |